China Pharma Holdings (CPHI) Debt Ratio (2010 - 2026)

China Pharma Holdings has reported Debt Ratio for 17 years, with the latest figure at 0.04 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 76.15% year-over-year to 0.04; the trailing twelve-month figure through Mar 2026 stood at 0.04 (down 76.15% YoY), and the FY2025 full-year result was 0.06, down 60.54% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.04, down from 0.06 in the prior quarter.
• The five-year high for Debt Ratio was 0.28 in Q3 2022, with the low at 0.04 in Q1 2026.
• Historically, Debt Ratio has averaged 0.16 across 5 years, with a median of 0.17 in 2024.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 41.03% — and 2026, when it tumbled 76.15%.
• China Pharma Holdings' Debt Ratio stood at 0.14 in 2022, then advanced by 12.62% to 0.15 in 2023, then climbed by 4.58% to 0.16 in 2024, then plunged by 60.54% to 0.06 in 2025, then slumped by 33.01% to 0.04 in 2026.
• The last three Debt Ratio figures came in at 0.04 (Q1 2026), 0.06 (Q4 2025), and 0.09 (Q3 2025), per Business Quant data.